Search Results - "LOBET, Y"

Refine Results
  1. 1

    Simultaneous presence of different Borrelia burgdorferi genospecies in biological fluids of Lyme disease patients by DEMAERSCHALCK, I, ABDELOUAHID BEN MESSAOUD, DE KESEL, M, HOYOIS, B, LOBET, Y, HOET, P, BIGAIGNON, G, BOLLEN, A, GODFROID, E

    Published in Journal of Clinical Microbiology (01-03-1995)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  2. 2

    Prospects for a better vaccine against tuberculosis by Reed, S.G., Alderson, M.R., Dalemans, W., Lobet, Y., Skeiky, Y.A.W.

    Published in Tuberculosis (Edinburgh, Scotland) (01-01-2003)
    “…There have been many new promising approaches to developing human vaccines against tuberculosis (TB). Advances in gene and antigen identification, availability…”
    Get full text
    Journal Article
  3. 3

    Inhibition of Borrelia burgdorferi-Tick Interactions In Vivo by Outer Surface Protein A Antibody by Pal, Utpal, Montgomery, Ruth R, Lusitani, Denise, Voet, Pierre, Weynants, Vincent, Malawista, Stephen E, Lobet, Yves, Fikrig, Erol

    Published in The Journal of immunology (1950) (15-06-2001)
    “…Borrelia burgdorferi outer surface protein (Osp) A is preferentially expressed by spirochetes in the Ixodes scapularis gut and facilitates pathogen-vector…”
    Get full text
    Journal Article
  4. 4

    Transmission of Borrelia garinii OspA serotype 4 to BALB/c mice by Ixodes ricinus ticks collected in the field by HU, C. M, WILSKE, B, FINGERLE, V, LOBET, Y, GERN, L

    Published in Journal of clinical microbiology (01-03-2001)
    “…In Europe, Borrelia garinii OspA serotype 4 has been isolated from the cerebrospinal fluid of patients but, up to now, has never been identified among culture…”
    Get full text
    Journal Article
  5. 5

    Developing a nontypeable Haemophilus influenzae (NTHi) vaccine by Poolman, J.T., Bakaletz, L., Cripps, A., Denoel, P.A., Forsgren, A., Kyd, J., Lobet, Y.

    Published in Vaccine (08-12-2000)
    “…There is a current high demand for nontypable Haemophilus influenzae (NTHi) vaccines. Various options for the composition of such vaccines are possible…”
    Get full text
    Journal Article
  6. 6

    Evaluation of genetic divergence among Borrelia burgdorferi isolates by use of OspA, fla, HSP60, and HSP70 gene probes by Wallich, R, Helmes, C, Schaible, U E, Lobet, Y, Moter, S E, Kramer, M D, Simon, M M

    Published in Infection and Immunity (01-11-1992)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults by Van Hoecke, C., Comberbach, M., De Grave, D., Desmons, P., Fu, D., Hauser, P., Lebacq, E., Lobet, Y., Voet, P.

    Published in Vaccine (01-12-1996)
    “…The safety, reactogenicity and immunogenicity of three candidate Lyme vaccines based on recombinant outer surface protein (OspA) presented in either lipidated…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi by GOLDE, W. T, PIESMAN, J, FRANTZ, J. C, DOLAN, M. C, KRAMER, M, HAUSER, P, LOBET, Y, CAPIAU, C, DESMONS, P, VOET, P, DEARWESTER, D

    Published in Infection and Immunity (01-03-1997)
    “…Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon…”
    Get full text
    Journal Article
  11. 11

    Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin by LOBET, Y, FERON, C, DEQUESNE, G, SIMOEN, E, HAUSER, P, LOCHT, C

    “…Pertussis toxin plays a major role in the pathogenesis of whooping cough and is considered an important constituent of vaccines against this disease. It is…”
    Get full text
    Journal Article
  12. 12

    Effect of site-directed mutagenic alterations on ADP-ribosyltransferase activity of the A subunit of Escherichia coli heat-labile enterotoxin by LOBET, T, CLUFF, C. W, CIEPLAK, W. JR

    Published in Infection and Immunity (01-09-1991)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  13. 13

    Tick transmission of Borrelia burgdorferi to inbred strains of mice induces an antibody response to P39 but not to outer surface protein A by GOLDE, W. T, KAPPEL, K. J, DEQUESNE, G, FERON, C, PLAINCHAMP, D, CAPIAU, C, LOBET, Y

    Published in Infection and Immunity (01-06-1994)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  14. 14

    Efficacy of Human Lyme Disease Vaccine Formulations in a Mouse Model by Telford, S. R., Kantor, F. S., Lobet, Y., Barthold, S. W., Spielman, A., Flavell, R. A., Fikrig, E.

    Published in The Journal of infectious diseases (01-05-1995)
    “…Although immunization with recombinant outer surface protein A (OspA) appears to protect mice against infection by the agent of Lyme disease, all reported…”
    Get full text
    Journal Article
  15. 15

    Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice by Fikrig, Erol, Flavell, Richard A, Alexopoulou, Lena, Thomas, Venetta, Schnare, Markus, Lobet, Yves, Anguita, Juan, Schoen, Robert T, Medzhitov, Ruslan

    Published in Nature Medicine (01-08-2002)
    “…The Lyme disease vaccine is based on the outer-surface lipoprotein (OspA) of the pathogen Borrelia burgdorferi, and 95% of vaccine recipients develop…”
    Get full text
    Journal Article Magazine Article
  16. 16

    Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites by Gern, L, Rais, O, Capiau, C, Hauser, P, Lobet, Y, Simoen, E, Voet, P, Pêtre, J

    Published in Immunology letters (01-03-1994)
    “…The wide distribution of Borrelia burgdorferi, the spirochete causing Lyme borreliosis, represents a human health hazard in many areas of the world…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Expression, refolding and crystallization of the OpcA invasin from Neisseria meningitidis by Prince, S. M., Feron, C., Janssens, D., Lobet, Y., Achtman, M., Kusecek, B., Bullough, P. A., Derrick, J. P.

    “…OpcA is an integral outer membrane from the Gram‐negative pathogen Neisseria meningitidis that plays a role in adhesion of meningococci to host cells. The…”
    Get full text
    Journal Article
  19. 19

    Development of a vaccine against Lyme disease by Lobet, Y.

    Published in Médecine et maladies infectieuses (01-05-1998)
    “…A vaccine against Lyme disease has been successfully tested in US endemie areas. It is based on the use of OspA, an outer surface protein of B. burgdorferi, to…”
    Get full text
    Journal Article
  20. 20

    Tuberculosis vaccine development; from mouse to man by Reed, Steven, Lobet, Yves

    Published in Microbes and infection (01-05-2005)
    “…A tuberculosis (TB) vaccine candidate, Mtb72, was developed following an antigen discovery program involving a combination of expression cloning strategies and…”
    Get full text
    Journal Article